EcoDrugPlus

Cannabinoid Receptor 2

Ensembl ID : ENSSMAG00000003186
Gene Symbol: CNR2
3 Cross references
191 Possible Orthologues:

Carbonic Anhydrase 12

Ensembl ID : ENSSMAG00000015506
Gene Symbol: CA12
3 Cross references
214 Possible Orthologues:

Carbonic Anhydrase Iv A

Ensembl ID : ENSSMAG00000000365
Gene Symbol: CA4A
1 Cross references
212 Possible Orthologues:

Carbonic Anhydrase Iv B

Ensembl ID : ENSSMAG00000004469
Gene Symbol: CA4B
2 Cross references
196 Possible Orthologues:

Carbonic Anhydrase Iv C

Ensembl ID : ENSSMAG00000019238
Gene Symbol: CA4C
3 Cross references
79 Possible Orthologues:

Carbonic Anhydrase Vii

Ensembl ID : ENSSMAG00000021339
Gene Symbol: CA7
3 Cross references
221 Possible Orthologues:

Carbonic Anhydrase Va

Ensembl ID : ENSSMAG00000015741
Gene Symbol: CA5A
3 Cross references
231 Possible Orthologues:

Casein Kinase 1, Epsilon

Ensembl ID : ENSSMAG00000007523
Gene Symbol: CSNK1E
1 Cross references
196 Possible Orthologues:

Casein Kinase I

Ensembl ID : ENSSMAG00000005548
Gene Symbol: LOC118288586
2 Cross references
211 Possible Orthologues:

Caspase 9, Apoptosis-Related Cysteine Peptidase

Ensembl ID : ENSSMAG00000009285
Gene Symbol: CASP9
2 Cross references
202 Possible Orthologues:

Catechol O-Methyltransferase-Like

Ensembl ID : ENSSMAG00000008166
Gene Symbol: LOC118319305
2 Cross references
177 Possible Orthologues:

Catechol-O-Methyltransferase B

Ensembl ID : ENSSMAG00000014805
Gene Symbol: COMTB
1 Cross references
215 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).